when were glp 1 agonists approved Indications for GLP-1/GIP RA Summary Sheet and Beyond! Evolution of GLP‐1 Receptor Agonists

The messaging is about affordability and access

Maintain metabolic health.*

Ozempic, Wegovy and Mounjaro accounted for nearly $4-billion in sales at retail pharmacies in 2025, according to IQVIA Canada

GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management

Some employers choose to exclude GLP-1 drugs from employer-sponsored health plans

Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers...